These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7318878

  • 21. Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites.
    Ching MS, Blake CL, Ghabrial H, Ellis SW, Lennard MS, Tucker GT, Smallwood RA.
    Biochem Pharmacol; 1995 Sep 07; 50(6):833-7. PubMed ID: 7575645
    [Abstract] [Full Text] [Related]

  • 22. Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.
    Zinny MA, Taggart WV.
    Clin Ther; 1984 Sep 07; 7(1):22-7. PubMed ID: 6518461
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Relative bioavailability of three commercial quinidine dosage forms.
    Sirois G, Eshaque M, Chabot M.
    Biopharm Drug Dispos; 1980 Sep 07; 1(4):167-77. PubMed ID: 7448345
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinical pharmacology of hydroxy-3(S)-dihydroquinidine in healthy volunteers following oral administration.
    Lecocq B, Jaillon P, Lecocq V, Ferry A, Gardin ME, Jarreau C, Leroyer R, Pays M, Jarreau FX.
    J Cardiovasc Pharmacol; 1988 Oct 07; 12(4):445-50. PubMed ID: 2465445
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Absolute quinidine bioavailability.
    Ueda CT, Williamson BJ, Dzindzio BS.
    Clin Pharmacol Ther; 1976 Sep 07; 20(3):260-5. PubMed ID: 954347
    [Abstract] [Full Text] [Related]

  • 29. [Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine].
    Leroyer R, Varoquaux O, Guillebastres R, Jarreau C, Normand JP, Jaillon P, Advenier C, Pays M.
    Therapie; 1986 Sep 07; 41(3):159-62. PubMed ID: 3750253
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Quinidine saliva concentrations: absence of correlation with serum concentrations at steady state.
    Narang PK, Carliner NH, Fisher ML, Crouthamel WG.
    Clin Pharmacol Ther; 1983 Nov 07; 34(5):695-702. PubMed ID: 6627830
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Studies on antiarrhythmic effects and toxicity of quinidine and dihydroquinidine as well as defined mixtures of both in rats (author's transl)].
    Dietmann K, Bartsch W, Gutekunst M.
    Arzneimittelforschung; 1977 Nov 07; 27(3):589-93. PubMed ID: 577425
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Bioavailability of quinidine in congestive heart failure.
    Ueda CT, Dzindzio BS.
    Br J Clin Pharmacol; 1981 Jun 07; 11(6):571-7. PubMed ID: 7272173
    [Abstract] [Full Text] [Related]

  • 39. Kinetics and electrocardiographic changes after oral 3-OH-quinidine in healthy subjects.
    Vozeh S, Uematsu T, Guentert TW, Ha HR, Follath F.
    Clin Pharmacol Ther; 1985 May 07; 37(5):575-81. PubMed ID: 3987181
    [Abstract] [Full Text] [Related]

  • 40. Relative bioavailability of quinidine gluconate and quinidine sulfate in healthy volunteers.
    Covinsky JO, Russo J, Kelly KL, Cashman J, Amick EN, Mason WD.
    J Clin Pharmacol; 1979 May 07; 19(5-6):261-9. PubMed ID: 469022
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.